Status:
COMPLETED
Systemic Pharmacokinetics of BOL-303224-A
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Conjunctivitis, Bacterial
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This is a multi-center, open-label, single dose/multiple dose, pharmacokinetic study in participants with bacterial conjunctivitis. The purpose of this study is to determine the extent of systemic exp...
Eligibility Criteria
Inclusion
- must be at least 18 years of age, any race
- must have a clinical diagnosis of acute bacterial conjunctivitis and exhibit purulent conjunctival discharge and redness in both eyes
- women of childbearing potential must utilize reliable contraceptive methods and have a negative pregnancy test
Exclusion
- Pregnant or nursing women
- known hypersensitivity to fluoroquinolones or to any of the ingredients in the study medication
- use of any antibiotic within 72 hours of enrollment
- participation in an ophthalmic drug or devise research study within 30 days prior to entry in this study
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00407589
Start Date
October 1 2006
End Date
October 1 2007
Last Update
December 9 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cornerstone Eyecare
High Point, North Carolina, United States, 27262